Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$16,292,683
+$490,615 QoQ
Shares Held
64,152
-0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.29%
of 13F equity value
Holder Rank
#846
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROWLANDMILLER & PARTNERS.ADV holds $61,867,127 across 7 Drug Manufacturers - General names. JNJ ranks #2 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,075 | $18,081,408 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
64,152 | $16,292,683 | |
| 3 | ABBV |
AbbVie Inc.
|
43,246 | $10,882,423 | |
| 4 | AMGN |
Amgen Inc
|
14,748 | $5,340,545 | |
| 5 | MRK |
Merck & Co., Inc.
|
37,007 | $4,755,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
36,350 | $4,592,459 | |
| 7 | PFE |
Pfizer Inc
|
79,826 | $1,922,210 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,292,683 | 64,152 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $15,802,068 | 64,646 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $13,651,870 | 65,967 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,286,670 | 66,264 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $10,593,212 | 69,350 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $11,530,026 | 69,525 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $10,151,456 | 70,194 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $11,392,331 | 70,297 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $10,312,611 | 70,557 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $11,352,505 | 71,765 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $11,232,458 | 71,663 | Shares | Sole | 2024-01-03 | |
| 2023-09-30 | $11,210,573 | 71,978 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $12,003,510 | 72,520 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $11,236,260 | 72,492 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $12,684,883 | 71,808 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $11,728,431 | 71,795 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $12,565,932 | 70,790 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,546,643 | 70,793 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $12,189,763 | 71,256 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,480,873 | 71,089 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $11,528,834 | 69,982 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $11,515,347 | 70,066 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $11,236,459 | 71,397 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $10,698,814 | 71,862 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,997,246 | 71,089 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $9,423,264 | 71,862 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||